FDA approves Eli Lilly's new oral weight-loss pill.

The FDA has approved orforglipron, an oral weight-loss pill from Eli Lilly, marking the first time an oral GLP-1 medication is approved for chronic weight management. It works by regulating appetite and was shown to significantly reduce weight in clinical trials. Common side effects include nausea, diarrhea, and vomiting.